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Background: Polycystic ovary syndrome (PCOS) is a common and complex
endocrinopathy with reproductive and metabolic manifestations. Exercise training has
consistently been found to result in improved clinical outcomes in women with PCOS,
but shortfalls with exercise prescription are evident. The aim of this systematic review and
meta-analysis was to identify exercise intervention characteristics that provide favourable
outcomes in women with PCOS.
Methods: A systematic review of published literature was conducted using EBSCOhost
and Ovid Medline up to May 2019. The review adheres to the Preferred Reporting Items
for Systematic Review and Meta-Analyses (PRISMA) guidelines as per our PROSPERO
protocol (CRD42018088367). Randomised controlled trials, non-randomised controlled
trials, and uncontrolled trials that evaluated an exercise intervention of at least moderate
intensity in women with PCOS were included. Meta-analyses were performed using
general linear mixed modelling and Bayesian inferences about effect magnitudes.
Results: Thirty-three articles were identified for systematic review of which 19 were
meta-analysed. Intervention duration ranged from 6 to 26 weeks. A total number
of 777 women were included in the meta-analysis. The meta-analysis found that
improvements in health outcomes are more dependent on exercise intensity rather than
dose. Fixed effects analysis reported a moderate increase in VO2peak (24.2%; 90% CL,
18.5–30.1), and small reductions in HOMA-IR (−36.2%; 90% CL, −55.3 to −9.0), and
waist circumference (−4.2%; 90% CL −6.0 to −2.3) as a result of vigorous intensity
exercise. These results are confirmed in the predicted analysis which reported the
greatest improvements in VO2peak, BMI, and waist circumference after vigorous intensity
exercise alone or when combined with diet, particularly for women with clinically adverse
baseline values.
Conclusions: Exercise training in the management of PCOS is becoming more
common. Results from our analysis support the use of exercise and suggest that
vigorous intensity exercise may have the greatest impact on cardiorespiratory fitness,
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body composition, and insulin resistance. Our results indicate that, a minimum of 120min
of vigorous intensity per week is needed to provide favourable health outcomes for
women with PCOS with studies of longer duration required to evaluate outcomes with
sustained exercise.
Keywords: lifestyle intervention, physical activity, resistance training, exercise intensity, cardiorespiratory fitness,
metabolic health, insulin resistance, high-intensity interval training
INTRODUCTION
Polycystic ovary syndrome (PCOS) is one of the most common
endocrine conditions, affecting 8–13% of reproductive aged
women (Teede et al., 2018a). PCOS is complex with diverse
features including reproductive, metabolic, and mental health
complications. PCOS is diagnosed via the internationally
endorsed Rotterdam criteria, which require the presence of
two or more features including clinical or biochemical signs of
hyperandrogenism, oligo- or anovulation, and polycystic ovaries
on ultrasound, with the exclusion of other aetiologies (Rotterdam
EA-SPCWG, 2004). Although not currently recognised in the
diagnostic criteria, insulin resistance is a key aetiological factor
contributing to the severity of reproductive and metabolic
features (Poretsky et al., 1999; Altuntas et al., 2003), with obesity
known to exacerbate the severity of clinical symptoms (Lim et al.,
2012). Consequently, women with PCOS are at a two to eight
times greater risk of developing impaired glucose tolerance and
type 2 diabetes mellitus compared to women without PCOS
(Moran et al., 2010).
Exercise is well-established as a therapy for preventing and
managing chronic diseases in the general population (Booth
et al., 2000; Roberts and Barnard, 2005), and in women with
PCOS (Wild et al., 2010; Teede et al., 2018a; Stepto et al.,
2019). The beneficial effects of exercise in women with PCOS
have been summarised in several recent systematic reviews
and meta-analyses (Benham et al., 2018; Kite et al., 2019).
In addition, the international evidence-based guidelines for
the management of PCOS recommend lifestyle intervention,
including exercise training and diet, as the first line of therapy
to improve general health, hormonal outcomes, and quality
of life (Teede et al., 2018a). However, the studies utilised in
the development of the guidelines were limited to a small
number of randomised controlled trials (RCTs), resulting in
a general consensus recommendation of exercise rather than
a clear exercise prescription for the management of PCOS
(Teede et al., 2018b; Stepto et al., 2019). In particular, there
is uncertainty about suitable intensity, duration, and modality
of exercise, and the interaction between exercise and diet. We
have addressed this uncertainty by meta-analysing the effects
of exercise characteristics on key clinical markers in women
with PCOS, with the aim of assisting clinicians with exercise
prescription and guiding future research in women with PCOS.
METHODS
Protocol and Registration
This systematic review and meta-analysis was conducted and
reported in accordance with the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) and was
registered on the International prospective register for systematic
reviews (PROSPERO) CRD42018088367.
Search Strategy, Study Selection, and Data
Extraction
We performed a systematic search of the literature to May
2019 inclusive using EBSCOhost (MEDLINE, SPORTDiscus,
PsycINFO, CINAHL) and Ovid Medline. The search was limited
to peer reviewed, published, English language articles from 1980-
current. The search terms were modified when required for
each database and are reported in Supplementary Table 1. The
reference lists of other review articles were searched to identify
other potential eligible studies. After removal of duplicates, two
reviewers (RB and RP) independently screened articles by title
and abstract. Subsequently, the same reviewers independently
completed full-text screening. Any discrepancies were resolved
by consensus or by consultation with a third reviewer (NS).
After full-text screening, data extraction of eligible studies was
performed independently by RB and RP using a pre-determined
extraction form.
Where required, authors were contacted via email using an
institutional email address in order to obtain additional or raw
data. Following a second email, if no response was received
within 14 days, the article was excluded from the meta-analysis.
Where multiple publications resulted from the same trial, results
were combined, and only one result (largest participant number)
for each outcome was used in the analysis.
Eligibility Criteria
The Participant, Intervention, Comparison, Outcomes, and
Studies (PICOS) framework was used for this systematic review
(Table 1). Briefly, included studies involved women aged 18–
45 (pre-menopausal) and with a diagnosis of PCOS via any
established diagnostic criteria. The interventions included RCTs,
non-randomised controlled trials, and uncontrolled trials that
had a pre-post design and reported outcomes of an exercise
training intervention greater than two weeks in duration,
and of moderate intensity or greater. Exercise intensity was
categorised according to Norton et al. (2010), classified as
moderate (55 to <70% HRmax or 40 to < 60% VO2max),
vigorous (70 to <90% HRmax or 60 to <85% VO2max), or
high (≥90% HRmax or ≥85% VO2max) intensity. Two weeks
was used as a minimum intervention duration in order to
capture the effects of exercise training. We accepted exercise
interventions that included aerobic exercise, resistance training,
or a combination. Exercise interventions that were combined
with a drug therapy that may affect the outcomes measures
were excluded. Exercise interventions that were combined with a
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TABLE 1 | Eligibility criteria for study inclusion.
Participant Intervention Comparator Outcome Study design Limits
Inclusion criteria





Any exercise intervention that is:
Supervised or unsupervised
Greater than 2 weeks in duration
Moderate intensity (>55% HRmax or




















HRmax , Maximal Heart Rate; VO2peak , Peak Oxygen Consumption; BMI, Body Mass Index; W/H Ratio, Waist to Hip Ratio; RCT, Randomised Controlled Trial.
dietary intervention or dietary advice were included. Comparison
groups consisted of a no exercise control group or a diet
only group. The primary outcomes specified for the meta-
analysis were peak oxygen consumption (VO2peak) used to
measure cardiorespiratory fitness, homeostatic model assessment
of insulin resistance (HOMA-IR) to measure insulin resistance,
free androgen index (FAI) to measure androgens, and body mass
index (BMI), and waist circumference to assess weight related
outcomes. Secondary outcomes were those that were included in
the systematic review only and consist of additional reproductive,
cardio-metabolic, or anthropometric outcomes (Table 1).
Assessment of Risk of Bias in Included
Studies
The Downs and Black Checklist for the Assessment of
Methodological Quality (Downs and Black, 1998) was used
to evaluate the included randomised and non-randomised
studies. Two reviewers (RB and RP) independently assessed
the methodological quality and disagreements were resolved by
consensus. Questions regarding blinding of participants were
removed from the checklist (Supplementary Table 2). As per
our previous meta-analysis (Cassar et al., 2016) publication bias
was assessed by examining a scatter plot of t-statistic associated
with each study estimate value contributing to the study-estimate
random effect versus log of the standard error of the effect. No
outliers or publication bias was identified using this approach.
Data Analysis
The meta-analyses were performed with the general linear
mixed-model procedure in the Statistical Analysis System
(Version 9.4, SAS Institute, Cary, NC, USA). The fixed effects
in the model were used to estimate the main effects of exercise
and its modifiers. A nominal variable represented type of
exercise (moderate, vigorous, resistance, control) and a linear
numeric variable represented total dose of any exercise (in
hours). A nominal variable with two levels (exercise, control) was
interacted with the baseline value of the dependant variable and
with a dummy variable representing a dietary co-intervention
(described as either a structured dietary plan, dietary advice,
or guidance) to estimate respectively the modifying effects
of baseline and of diet in exercise and control groups. The
linear numeric effect of baseline HOMA-IR produced unrealistic
predictions at low values of this dependant variable, so the
numeric variable was replaced by a nominal variable with three
levels defined by the following: low, <2.1; moderate, 2.1–3.4;
high, >3.4.
A random effect representing the identity of each study
estimate was included to allow for differences in the means
of study estimates not accounted for by the fixed effects,
and an additional random effect representing estimate identity
accounted for study clusters of estimates (control and/or one or
more experimental estimates). In the mixed-model, each study
estimate was weighted by the inverse of the square of its standard
error (SE), and the random effects were estimated by setting the
residual variance to unity (Yang, 2003). The standard error of
each estimate was either derived as the standard deviation (SD)
of change scores divided by the square root of the sample size or
was computed with a spreadsheet from either the exact p-value
or compatibility intervals for the mean change. For estimates
where the standard error could not be derived from the data,
it was imputed from the error of measurement averaged over
other similar estimates (Supplementary Table 3). The number of
imputed standard errors represented 0.1–3% of the total number,
depending on the meta-analysed measure.
All study-estimates, standard errors, and baseline between-
subject SDs were converted to factor effects by dividing by
the group mean and then log-transformed for the meta-
analysis. The qualitative magnitudes of meta-analysed mean
effects were evaluated via standardisation using magnitude
thresholds provided by an appropriate baseline between-subject
SD (Hopkins et al., 2009). This SD was derived by combining
(via variances) the mean of the study SDs with the between-
study SD of the study baseline means, to represent the SD of
women drawn randomly from a population of sub-populations.
The threshold for the smallest important effect (0.2 SD) was
rounded down towards the mean of the study SD to allow for
differences in study means to be due partly to differences in assay
technique; the thresholds for small, moderate, large, very large,
and extremely large were 1, 3, 6, 10, and 20 times the smallest
important threshold, respectively (corresponding to 0.2, 0.6,
1.2, 2.0, and 4.0 times the SD, Supplementary Table 4) (Cassar
et al., 2016). These thresholds were also used to evaluate the
magnitude of the numeric linearmodifying effects of baseline and
training duration, by multiplying the beta-coefficients (slopes) in
the model by two between-subject SD and between-study SD,
respectively (Hopkins et al., 2009). The thresholds were halved
for evaluation of the magnitude of the random-effect SDs (Smith
and Hopkins, 2011). The meta-analysis also provided predicted
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FIGURE 1 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) study selection flow diagram.
population and individual-setting effects of various combinations
of exercise, diet and baseline values for the dependent variable.
The predicted effects for individual settings had the same value
as the predicted population mean effects, but their compatibility
intervals were wider, owing to the contribution of the between-
and within-study random effects.
Uncertainty in the estimates of effects is presented as 90%
compatibility limits. Probabilistic decisions about true (large-
sample) magnitudes accounting for the uncertainty were based
on one-sided hypothesis tests of substantial magnitudes (Lakens
et al., 2018). The p-value for rejecting a hypothesis of a given
magnitude was the area of the sampling t distribution of the
effect statistic with values of that magnitude. For effect modifiers,
random-effect SDs, and predicted population mean effects,
hypotheses of substantial decrease, and increase were rejected
if their respective p-values were <0.05. For predicted effects in
individual settings, hypotheses of harm, and benefit were rejected
if the respective p-values were <0.005 and 0.25. If one hypothesis
was rejected, the p-value for the other hypothesis was interpreted
as evidence for that hypothesis, since the p-value corresponds
to the posterior probability of the magnitude of the true effect
in a reference Bayesian analysis with a minimally informative
prior (Hopkins and Batterham, 2018; Hopkins, 2019). The p-
value is reported qualitatively using the following scale: 0.25–
0.75, possibly; 0.75–0.95, likely; 0.95–0.995, very likely; >0.995,
most likely (Hopkins et al., 2009). This scale was also used to
interpret the posterior probability of a true trivial effect, which
is given by the area of the sampling distribution in trivial values.
If neither hypothesis was rejected, the magnitude of the effect
was considered to be unclear, and the magnitude of the effect
is shown without a probabilistic qualifier. To reduce inflation
of error arising from the large number of effects investigated,
effects were considered decisive with more conservative p-value
thresholds (p < 0.01 for a substantial decrease or increase; p <
0.001 for harm; p < 0.05 for benefit) and are formatted bold in
tables and figures.
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RESULTS
The combined searches identified 1,476 papers for review. Of
these, 635 were excluded due to duplication, 784 were removed
by title and abstract screening, with 57 full-text articles reviewed.
Twenty-four of these were excluded due to medication use,
lack of data on outcomes of interest and intervention type,
with 33 publications deemed suitable for inclusion in the
systematic review. Multiple publications were identified for
six exercise intervention studies and thereafter amalgamated
with the largest reported number (N) for outcome measures
of interest carried forward for meta-analysis. The remaining
20 articles were included in the systematic review with one
article excluded from the meta-analysis due to using a non-
parametric analysis (Brown et al., 2009) (Figure 1). A summary
of study and participant characteristics, exercise intervention,
and study outcomes is reported in Table 2 and results of the
methodological quality are presented in Table 4 (for full results
see Supplementary Table 5).
Summary of Articles
Of the 20 trials included in the systematic review, 10 were RCTs
(Bruner et al., 2006; Vigorito et al., 2007; Thomson et al., 2008;
Brown et al., 2009; Jedel et al., 2011; Ladson et al., 2011; Nybacka
et al., 2011; Almenning et al., 2015; Orio et al., 2016; Costa et al.,
2018), five non-randomised uncontrolled trials (Randeva et al.,
2002; Giallauria et al., 2008; Hutchison et al., 2012; Covington
et al., 2016; Miranda-Furtado et al., 2016), one randomised
parallel trial (Curi et al., 2012), and one non-randomised parallel
trial (Orio et al., 2008), one randomised cross-over trial (Roessler
et al., 2013), one single arm trial (Sprung et al., 2013a), and one
non-randomised controlled trial (Sprung et al., 2013b). Themean
age of participants ranged from 22 to 32 years. Baseline BMI
ranged from 26.1 to 38.3 kg/m2. Participants from 16 studies
were diagnosed according to the Rotterdam criteria (Randeva
et al., 2002; Bruner et al., 2006; Vigorito et al., 2007; Giallauria
et al., 2008; Orio et al., 2008; Thomson et al., 2008; Jedel et al.,
2011; Nybacka et al., 2011; Curi et al., 2012; Roessler et al.,
2013; Sprung et al., 2013a,b; Almenning et al., 2015; Covington
et al., 2016; Miranda-Furtado et al., 2016; Costa et al., 2018)
and the remaining four studies used the NIH diagnostic criteria
(Brown et al., 2009; Ladson et al., 2011; Hutchison et al., 2012;
Orio et al., 2016). Sample sizes ranged from 5 to 62. Of the
20 reported interventions, 13 had full intervention supervision
(Bruner et al., 2006; Vigorito et al., 2007; Giallauria et al., 2008;
Orio et al., 2008, 2016; Brown et al., 2009; Nybacka et al.,
2011; Hutchison et al., 2012; Sprung et al., 2013a,b; Covington
et al., 2016; Costa et al., 2018), two had partial supervision
(at least one supervised session per week; Ladson et al., 2011;
Almenning et al., 2015), three had no supervision (Randeva
et al., 2002; Jedel et al., 2011; Curi et al., 2012), and two did
not report on supervision (Thomson et al., 2008; Roessler et al.,
2013). Practitioners that supervised the exercise intervention
included exercise physiologists, physiotherapists and physical
activity educators.
Fourteen studies involved only a continuous aerobic
intervention (Randeva et al., 2002; Vigorito et al., 2007;
Giallauria et al., 2008; Orio et al., 2008, 2016; Brown et al.,
2009; Jedel et al., 2011; Ladson et al., 2011; Nybacka et al., 2011;
Curi et al., 2012; Sprung et al., 2013a,b; Covington et al., 2016;
Costa et al., 2018), three had a high intensity aerobic interval
training group (Hutchison et al., 2012; Roessler et al., 2013;
Almenning et al., 2015), three had a resistance training group
(Thomson et al., 2008; Almenning et al., 2015; Miranda-Furtado
et al., 2016) and two had a combined resistance training and
aerobic group (Bruner et al., 2006; Thomson et al., 2008). Of
the interventions that included an aerobic exercise component,
three included high intensity aerobic intervals (Hutchison
et al., 2012; Roessler et al., 2013; Almenning et al., 2015), five
included vigorous intensity exercise (Bruner et al., 2006; Vigorito
et al., 2007; Giallauria et al., 2008; Orio et al., 2008, 2016), two
included moderate to vigorous intensity exercise (Thomson
et al., 2008; Costa et al., 2018) and nine included moderate
intensity exercise (Randeva et al., 2002; Brown et al., 2009;
Jedel et al., 2011; Ladson et al., 2011; Nybacka et al., 2011; Curi
et al., 2012; Sprung et al., 2013a,b; Covington et al., 2016). The
duration and frequency of exercise interventions ranged from
8 to 26 weeks and 2 to 5 sessions per week, respectively. The
length of individual session duration varied, ranging from 30
to 90 min.
Seventeen studies measured VO2peak (Randeva et al., 2002;
Bruner et al., 2006; Vigorito et al., 2007; Giallauria et al., 2008;
Orio et al., 2008, 2016; Thomson et al., 2008; Brown et al.,
2009; Jedel et al., 2011; Ladson et al., 2011; Hutchison et al.,
2012; Roessler et al., 2013; Sprung et al., 2013a,b; Almenning
et al., 2015; Covington et al., 2016; Costa et al., 2018). Of
these studies, 16 reported significant improvements following an
exercise intervention (Randeva et al., 2002; Bruner et al., 2006;
Vigorito et al., 2007; Giallauria et al., 2008; Orio et al., 2008,
2016; Thomson et al., 2008; Brown et al., 2009; Jedel et al.,
2011; Hutchison et al., 2012; Roessler et al., 2013; Sprung et al.,
2013a,b; Almenning et al., 2015; Covington et al., 2016; Costa
et al., 2018). Nineteen studies measured metabolic outcomes
(Randeva et al., 2002; Bruner et al., 2006; Vigorito et al., 2007;
Giallauria et al., 2008; Orio et al., 2008, 2016; Thomson et al.,
2008; Brown et al., 2009; Jedel et al., 2011; Ladson et al., 2011;
Nybacka et al., 2011; Curi et al., 2012; Hutchison et al., 2012;
Sprung et al., 2013a,b; Almenning et al., 2015; Covington et al.,
2016; Miranda-Furtado et al., 2016; Costa et al., 2018), 11 of
which reported significant changes in at least one marker of
metabolic health (Bruner et al., 2006; Vigorito et al., 2007;
Giallauria et al., 2008; Orio et al., 2008, 2016; Thomson et al.,
2008; Ladson et al., 2011; Hutchison et al., 2012; Sprung et al.,
2013b; Almenning et al., 2015; Covington et al., 2016). Four
studies reported significant decreases in HOMA-IR (Thomson
et al., 2008; Hutchison et al., 2012; Almenning et al., 2015;
Orio et al., 2016), eight studies reported decreases in fasting
insulin levels (Bruner et al., 2006; Vigorito et al., 2007; Giallauria
et al., 2008; Orio et al., 2008, 2016; Thomson et al., 2008;
Hutchison et al., 2012; Almenning et al., 2015), three reported
significant improvements in glucose infusion or glucose disposal
rates (Hutchison et al., 2012; Covington et al., 2016; Orio et al.,
2016), five studies reported positive increases in HDL (Orio et al.,
2008, 2016; Ladson et al., 2011; Almenning et al., 2015; Covington

























TABLE 2 | Summary of studies identified for systematic review detailing participants, intervention characteristics and main outcomes measures.
Study Study
design


















Almenning et al. (2015) RCT 17 HIIT = 8
RT = 8
(25)
Age = 27.2 ± 5.5
RT: BMI = 27.4 ±
6.9





























Bruner et al. (2006) RCT 10 7 (12) Age = 32.3 ± 1
BMI = 36.2 ± 2






↑ VO2peak ↓ Fasting Insulin No change ↓ WC









↑ VO2peak No change Not measured ↓ BMI,
↓ WC
Curi et al. (2012) Randomised
parallel trial
11 12 (27) Age = 26.3 ± 1.4






Not measured No change No change ↓ BMI,
↓ WC
Giallauria et al. (2008) Uncontrolled
trial
17 62 (124) Age = 22.8 ± 3.7







↑ VO2peak ↓ Fasting Insulin,
↓ AUCins,
↑ AUCglu/AUC ins
↑ SHBG ↓ BMI,
↓ W/H
Hutchison et al. (2011)
Moran et al. (2011)
Hutchison et al. (2012)







13 (21) Age = 29.75 ± 1.4
BMI = 35.6 ± 5.8













Ladson et al. (2011) RCT 17 59 (114) Age = 28.8 ± 4.6






No change ↑ AUCglu,
↑ HDL




































































TABLE 2 | Continued
Study Study
design



















Kogure et al. (2016)






45 (97) Age = 28.1 ± 5.4
BMI = 28.4 ± 6
Rotterdam Type: RT
Frequency: 3/weeks
Intensity: % of 1RM
Duration: 16 weeks
Supervision: Full




Moro et al. (2009)
Redman et al. (2011)
Covington et al. (2015)







8 (16) Age = 25.6 ± 3.1







↑ VO2peak ↑ GDR,
↑ HDL
No change No change
Nybacka et al. (2011)







Age = 31.8 ± 4.9











Orio et al. (2016) RCT 18 39 (136) Age = 25.9 ± 2.7














No change ↓ BMI,
↓ W/H
Orio et al. (2008) Non-
randomised
parallel study
14 32 (64) Age = 18-40












No change ↓ BMI
↓ WC,
↓ W/H
Randeva et al. (2002) Uncontrolled
trail
12 12 (21) Age = 29.7 ± 6.8






↑ VO2peak No Change Not measured ↓ W/H
Roessler et al. (2013) Randomised
crossover trial
15 8 (17) Age = 31 (SEM−3)
BMI =
34.8 (SEM-2.5)














































































TABLE 2 | Continued
Study Study
design

















Sprung et al. (2013a) Single-arm
trial
15 6 (12) Age = 28 (25 – 31)







↑ VO2peak No change No change No change
Sprung et al. (2013b) Non-RCT 14 10 (17) Age = 29 ± 7











No change No change








30 (74) Age = 30.2 ± 4.7











Thomson et al. (2008)
Thomson et al. (2012)











Age = 29.3 ± 6.8
BMI = 36.1 ± 4.8
Rotterdam Type: Aerobic, RT or





















Vigorito et al. (2007) RCT 15 45 (90) Age = 21.7 ± 2.3

















Included for systematic review only
Brown et al. (2009) RCT 17 8 (20) Age = 36.5 (5)







↑ VO2peak No change Not measured No change
QA, Quality Assessment; CRF- Cardiorespiratory Fitness; RCT, Randomised Controlled Trial; NIH, National Institute of Health; HIIT, High Intensity Interval Training; RT, Resistance Training; BMI, Body Mass Index; HRmax , Maximal Heart
Rate; VO2peak , Peak Oxygen Uptake; HRR, Heart Rate Reserve; N/R, Not Reported; ↑ Increase, ↓ Decrease, HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; AUC, Area Under the Curve; GDR, Glucose Disposal Rate;
GIR, Glucose Infusion Rate; HDL, High Density Lipoproteins; LDL, Low Density Lipoproteins; AMH, Anti-Mullerian Hormone; SHBG, Sex Hormone Binding Globulin; FAI, Free Androgen Index; T, Testosterone; Free T, Free Testosterone;
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TABLE 3 | Meta-analysed effects on peak oxygen uptake (VO2peak ), body mass index (BMI) and waist circumference expressed as population mean effects in control and
exercise groups, and as modifying effects of exercise duration, baseline, and dietary co-intervention.
VOb2peak BMI
c Waist circumferenced
Mean (%) 90% CL (%) Magnitude Mean (%) 90% CL (%) Magnitude Mean (%) 90% CL (%) Magnitude
Population mean effectsa
Control group 1.0 −2.3, 4.4 Trivialooo 0.7 −0.2, 1.7 Trivial0000 0.8 −1.2, 2.8 Trivial00
Moderate exercise 18.4 11.2, 26.1 Moderate↑**** −0.9 −2.0, 0.3 Trivial0000 −1.6 −3.7, 0.5 Trivial00
Vigorous exercise 24.2 18.5, 30.1 Moderate↑**** −2.6 −3.6, −1.7 Trivial000 −3.4 −5.3, −1.5 Small↓**
Moderate—control group 17.2 9.7, 25.3 Moderate↑*** −1.6 −2.9, −0.2 Trivial0000 −2.4 −4.1, −0.6 Small↓*
Vigorous—control group 22.9 16.9, 29.2 Moderate↑**** −3.3 −4.5, −2.2 Trivial00 −4.2 −6.0, −2.3 Small↓**
Modifying effects
Baseline in control group 4.9 −1.4, 11.6 Trivial0 1.3 −1.2, 3.9 Trivial000 0.8 −2.9, 4.7 Trivial
Baseline in exercise group −10.3 −17.6, −2.4 Small↓** 0.8 −1.3, 3.0 Trivial000 −2.2 −5.9, 1.8 Small↓*
30 h of exercise duration −0.8 −7.8, 6.8 Trivial −1.3 −2.8, 0.2 Trivial0000 −3.6 −6.0, −1.2 Small↓**
Diet in control group −1.9 −11.1, 8.2 Trivial −5.6 −8.4, −2.7 Small↓** −7.5 −10.7, −4.3 Moderate↓***
Diet in exercise group −1.4 −10.0, 8.0 Trivial −2.9 −4.6, −1.2 Trivial00 −1.0 −4.3, 2.5 Trivial00
aEvaluated at mean baseline (VO2peak = 24mL.kg.min
-1, BMI = 31 kg.m2, waist circumference = 97 cm), training time = 30 h, and no dietary co-intervention.
bModifying effect of baseline is evaluated per 70% difference in baseline value.
cModifying effect of baseline is evaluated per 40% difference in baseline value.
dModifying effect of baseline is evaluated per 25% difference in baseline value.
90% CL 90% compatibility limits, ↑ increase, ↓ decrease.
Effects are shown with their observed magnitudes, determined by standardisation. Clear effects are show with the probability of either a true substantial change (*possibly, **likely, ***very
likely, ****most likely) and/or a true trivial change (0possibly, 00 likely, 000very likely, 0000most likely). Magnitudes in bold are clear with 99% compatibility intervals.
et al., 2016) and eight studies reported no changes in markers
of metabolic health following an exercise intervention (Randeva
et al., 2002; Brown et al., 2009; Jedel et al., 2011; Nybacka et al.,
2011; Curi et al., 2012; Sprung et al., 2013a; Miranda-Furtado
et al., 2016; Costa et al., 2018). Sixteen studies measured changes
in hormonal markers and reproductive health (Randeva et al.,
2002; Bruner et al., 2006; Vigorito et al., 2007; Giallauria et al.,
2008; Orio et al., 2008, 2016; Thomson et al., 2008; Jedel et al.,
2011; Ladson et al., 2011; Nybacka et al., 2011; Curi et al.,
2012; Hutchison et al., 2012; Sprung et al., 2013a,b; Almenning
et al., 2015; Covington et al., 2016; Miranda-Furtado et al.,
2016). Five studies reported a significant increase in sex hormone
binding globulin (SHBG) levels (Giallauria et al., 2008; Thomson
et al., 2008; Jedel et al., 2011; Almenning et al., 2015; Miranda-
Furtado et al., 2016), three studies reported significant decreases
in FAI (Thomson et al., 2008; Almenning et al., 2015; Miranda-
Furtado et al., 2016), two studies reported significant decreases
in anti-mullerian hormone (AMH) levels (Hutchison et al., 2012;
Almenning et al., 2015), three studies reported improvements in
menstrual cyclicity (Vigorito et al., 2007; Thomson et al., 2008;
Nybacka et al., 2011) and eight studies reported no changes
in reproductive outcomes post exercise intervention (Bruner
et al., 2006; Orio et al., 2008, 2016; Ladson et al., 2011; Curi
et al., 2012; Sprung et al., 2013a,b; Covington et al., 2016). All
20 studies measured changes in body composition following
exercise intervention. Sixteen reported significant changes in at
least one measure of body composition (Randeva et al., 2002;
Bruner et al., 2006; Vigorito et al., 2007; Giallauria et al., 2008;
Orio et al., 2008, 2016; Thomson et al., 2008; Jedel et al., 2011;
Ladson et al., 2011; Nybacka et al., 2011; Curi et al., 2012;
Hutchison et al., 2012; Roessler et al., 2013; Almenning et al.,
2015; Miranda-Furtado et al., 2016; Costa et al., 2018). Ten
studies reported significant decreases in BMI (Vigorito et al.,
2007; Giallauria et al., 2008; Orio et al., 2008, 2016; Jedel et al.,
2011; Nybacka et al., 2011; Curi et al., 2012; Hutchison et al.,
2012; Roessler et al., 2013; Costa et al., 2018), nine reported
decreases in waist circumference (Bruner et al., 2006; Vigorito
et al., 2007; Thomson et al., 2008; Ladson et al., 2011; Curi et al.,
2012; Roessler et al., 2013; Miranda-Furtado et al., 2016; Orio
et al., 2016; Costa et al., 2018), five reported decreases in waist
to hip ratio (Randeva et al., 2002; Vigorito et al., 2007; Giallauria
et al., 2008; Orio et al., 2008, 2016), three report decreased weight
(Thomson et al., 2008; Jedel et al., 2011; Roessler et al., 2013).
The remaining four studies reported no significant changes in any
measure of body composition (Brown et al., 2009; Sprung et al.,
2013a,b; Covington et al., 2016).
Meta-Analysis
The results from the meta-analysis of the effect of exercise
characteristics on cardiorespiratory fitness measured by VO2peak,
body composition (BMI and WC), insulin resistance (HOMA-
IR) and hyperandrogenism as measured by FAI are presented
as the population mean effects and modifying effects of exercise
characteristics (Tables 2, 3) and predicted effects of exercise
across various durations and baseline values (Figures 2–4).
Effect of Exercise on VO2peak
Meta-analysis from 16 studies with a total population of
600 women with PCOS, revealed moderate improvements in
VO2peak after moderate and vigorous intensity aerobic exercise,
with the largest increase was seen after vigorous intensity
exercise (Table 3). Across all conditions, the modifying effects
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FIGURE 2 | Predicted effects of exercise alone or exercise plus diet versus a control group on peak oxygen uptake (VO2peak ) after 20 h (A), 30 h (B), and 50 h (C) of
moderate (Mod), or vigorous (Vig) intensity exercise in an individual study setting. Clear effects are shown with the probability of a true substantial change (***very likely,
****most likely). Magnitudes in bold are clear with 99% compatibility intervals.
of intervention duration and dietary co-intervention on VO2peak
were trivial.
The predicted effects analysis showed that irrespective of
training dose, vigorous intensity aerobic exercise alone had the
most substantial increase in VO2peak (Figure 2). Moreover, it is
clear that baseline value plays a major role in the magnitude of
improvements, with lower baseline VO2peak values resulting in
the largest improvements.
Effects of Exercise on BMI
Meta-analysis of 17 studies which included a total of 759 women
with PCOS were included to determine the effect of exercise
on BMI. The predicted mean results of each intervention were
trivial (Table 3). The largest reductions in BMI were reported for
women undertaking vigorous intensity exercise compared to a
control group. The modifying effects of baseline BMI, duration
and diet were also trivial with the exception of the effect of diet in
a control group which resulted in a small decrease in BMI.
In the predicted effects analysis, training dose appears to
have a limited effect on BMI outcome. The addition of diet
intervention to exercise resulted in clear reductions in BMI.
Notably, vigorous intensity exercise combined with a dietary
intervention potentiated BMI changes, with small to moderate
reductions of BMI across all baseline BMIs and training durations
(Figure 3).
Effects of Exercise on Waist Circumference (WC)
Thirteen studies which included 463 women overall were used
in this analysis of the fixed effects of exercise on WC. Vigorous
intensity exercise when compared to a control group resulted in
the greatest reductions in WC. The modifying effect of diet in a
control group resulted in amoderate decrease inWC. In contrast,
there was a trivial effect of diet in the exercise group (Table 3).
The predicted effects analysis found the greatest improvement
in WC with a combined vigorous intensity aerobic exercise
and diet across the range of baseline WCs (Figure 3). Greater
improvements were seen in women with a higher baseline WC.
It was also apparent that training dose had a clear moderating
effect on WC with greater decreases being reported after 50 h of
exercise in comparison to 20 h of exercise (Figure 3).
Effects of Exercise on Free Androgen Index (FAI)
Sixteen studies were included in the meta-analysis of exercise-
induced changes in hyperandrogenism as measured by FAI and
included a total of 667 womenwith PCOS. Of the 16 studies, three
included a resistance training intervention. Our analysis showed
that the greatest improvements in FAI occurred after resistance
training (Table 3). Both moderate and vigorous aerobic exercise
resulted in only trivial changes. The effect of diet resulted in a
small decrease in FAI in both the exercise and control groups
(Table 3).
The predicted effects analysis also reported trivial changes in
FAI after aerobic exercise. Resistance training when combined
with diet had the largest effect on FAI, resulting in small to
moderate reductions of FAI across all baseline values and training
doses, however the results were mostly unclear (Figure 4). It is
apparent from the analysis that training duration plays a role in
the extent of improvements in FAI, with the largest effects being
seen after 50 h of exercise.
Effects of Exercise on Insulin Resistance (HOMA-IR)
Eleven studies (307 women with PCOS) were included in the
meta-analysis for the effect of exercise on HOMA-IR. Vigorous
intensity aerobic exercise and resistance training both resulted in
moderate reductions in HOMA-IR when compared to a control
group (Table 4). The modifying effect of diet on HOMA-IR
resulted in a moderate reduction in a no-exercise control group,
and a small reduction in an exercise group. The modifying effect
of baseline in a control group resulted in moderate increases in
HOMA-IR but only trivial effects in an exercise group (Table 4).
The predicted effects analysis on the effects of exercise on
HOMA-IR show that clear improvements in HOMA-IR were
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FIGURE 3 | Predicted effects of exercise alone or exercise plus diet versus a control group on body mass index (BMI) and waist circumference (WC) after 20 h
(A,D), 30 h (B,E), and 50 h (C,F) of moderate (Mod), or vigorous (Vig) intensity exercise in an individual study setting. Clear effects are shown with the probability of
either a true substantial change (*possibly, **likely, ***very likely) and/or a true trivial change (0possibly, 00 likely). Magnitudes in bold are clear with 99% compatibility
intervals.
only seen after vigorous intensity exercise both alone and
vigorous exercise when combined with a dietary intervention,
resulting in moderate reductions, irrespective of training dose
(Figure 4).
DISCUSSION
This is the first systematic review and meta-analysis to
evaluate the effectiveness of varying exercise intensities and the
moderating effects of dietary co-intervention, training dose, and
baseline values on cardiorespiratory, metabolic, and reproductive
health outcomes in women with PCOS. Results from this
systematic review demonstrate clear improvements in several
of these outcomes following an exercise intervention in women
with PCOS. The most consistent improvements were seen
with cardiorespiratory fitness (VO2peak), BMI, WC, and various
markers of metabolic health, including fasting insulin, and
HOMA-IR. These results are supported by our meta-analysis,
which revealed improvements in VO2peak, body composition and
insulin sensitivity following an exercise intervention, particularly
when compared to a no-exercise control group. Vigorous
intensity exercise, both alone and when combined with a
dietary intervention, resulted in the greatest improvements
in health parameters in both the fixed effects and predicted
effects analyses. Moderate intensity exercise resulted in clear
improvements in VO2peak, WC, and BMI when combined with
diet as seen in the predicted analysis. Interestingly, resistance
training showed promising improvements in FAI and HOMA-
IR in both fixed effect and predicted analyses, however further
research is required to confirm these improvements.
This systematic evaluation of exercise interventions align with
identified knowledge gaps in current international evidence-
based guidelines (Teede et al., 2018a; Stepto et al., 2019) and
meta-analyses (Benham et al., 2018; Kite et al., 2019) recently
undertaken in this population of women. There is substantial
evidence that supports the effectiveness of aerobic exercise
training for improving some health outcomes in women with
PCOS. In particular, aerobic exercise of various intensities has
consistently been found to result in improvements in VO2peak
in women with PCOS (Haqq et al., 2015; Kite et al., 2019;
Stepto et al., 2019). VO2peak is a measure of cardiorespiratory
fitness and is an important indicator of health and mortality
(Blair et al., 1989). Individuals with a lower VO2peak are at an
increased risk of all-cause mortality and morbidity with the risk
of death being more dependent on cardiorespiratory fitness than
BMI (Barry et al., 2014). To illustrate this point, with each 3.5
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FIGURE 4 | Predicted effects of exercise alone or exercise plus diet versus a control group on free androgen index (FAI) and homeostatic model assessment of insulin
resistance (HOMA-IR) after 20 h (A,D), 30 h (B,E), and 50 h (C,F) of moderate (Mod), vigorous (Vig) intensity exercise, or resistance training (RT) in an individual study
setting. Clear effects are shown with the probability of either a true substantial change (*possibly, **likely) and/or a true trivial change (0possibly, 00 likely). Baseline
HOMA-IR: Low, <2.1%; Moderate (Mod), 2.1–3.4%; High, >3.4%. Magnitudes in bold are clear with 99% compatibility intervals.
mL/kg/min increase in VO2peak, there is an associated 13% risk
reduction from all-cause mortality (Kodama et al., 2009). Based
on observed improvements from our meta-analysis, women with
PCOS and relatively low VO2peak of 24mL/kg/min are likely to
experience a ∼30% risk reduction in all-cause mortality after
30 h of vigorous intensity exercise over 10–12 weeks, irrespective
of any dietary co-intervention. An increase in exercise intensity
becomes of paramount importance for improving VO2peak in
women with high baseline values. These results expand on
existing studies that have reported improvements in VO2peak
after vigorous or high intensity exercise interventions (Harrison
et al., 2012; Roessler et al., 2013; Almenning et al., 2015; Costa
et al., 2018) and highlights the importance of exercise intensity
when prescribing exercise training in clinical practice or as part
of a clinical trial.
A large proportion of women with PCOS are overweight or
obese, with a recent meta-analysis reporting a pooled prevalence
of 61% (Lim et al., 2012). It is therefore not surprising that
many exercise and dietary interventions have an ultimate aim
of reducing body weight/BMI. Modest weight loss of 5–10% in
overweight women with PCOS is encouraged to yield clinical
improvements (Teede et al., 2018a). However, it is important to
note that health benefits can occur without significant weight
loss (Hutchison et al., 2011; Sprung et al., 2013b; Covington
et al., 2016). The lack of improvement in BMI following an
exercise only intervention observed from our analysis is not
surprising. However, when exercise is complimented with a
dietary intervention, small, but clear, decreases in BMI can
be achieved. In addition, our results support the inclusion
of diet in order to promote improvements in WC. Research
conducted by Thomson et al. (2008) reported reductions in body
weight and waist circumference of ∼10% across three different
treatments groups (diet alone, diet + aerobic exercise, or diet
+ combined aerobic and resistance exercise) after 20 weeks. A
study conducted by Bruner et al. (2006) reported no significant
differences in body weight or BMI following an intervention of
either nutritional counselling or a combined resistance training,
aerobic exercise and nutritional counselling intervention. They
did, however, report significant decreases in waist circumference
of 5% in both groups following the intervention period. BMI
as a measure of obesity is considered to have its limitations,
with changes in BMI not necessarily reflecting changes in body
fat (Rothman, 2008). Body composition assessment using direct
methods such as dual-energy X-ray absorptiometry (DXA) may
provide valuable information on changes in body composition.
When deprived of DXA information, measures of WC may
provide a better measure of obesity-related health risk than BMI
(Janssen et al., 2004). It is possible that exercise training alone
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TABLE 4 | Meta-analysed effects on homeostatic model assessment of insulin resistance (HOMA-IR) and free androgen index (FAI) expressed as population mean effects
in control and exercise groups, and as modifying effects of exercise duration, baseline, and dietary co-intervention.
HOMA-IRb FAIc
Mean (%) 90% CL (%) Magnitude Mean (%) 90% CL (%) Magnitude
Population mean effectsa
Control group 32.4 1.3, 72.9 Small↑** −2.9 −11.1, 6.1 Trivial000
Moderate exercise 10.1 −6.7, 30.0 Small↑* 2.2 −6.7, 12.0 Trivial000
Vigorous exercise −15.6 −33.2, 6.7 Small↓* 2.4 −7.4, 13.2 Trvial00
Resistance exercise −1.0 −14.4, 14.5 Trivial −15.3 −28.4, 0.2 Small↓*
Moderate—control group −16.8 −38.8, 13.1 Small↓* 5.2 −6.2, 18.0 Trivial00
Vigorous—control group −36.2 −55.3, −9.0 Moderate↓** 5.4 −6.1, 18.4 Trivial00
Resistance—control group −25.2 −44.4, 0.6 Moderate↓** −12.3 −27.3, 4.6 Small↓*
Modifying effects
Baseline in control group 43.9 11.7, 85.4 Moderate↑** 7.5 −11.5, 30.6 Small↑*
Baseline in exercise group 13.1 −25.1, 70.9 Trivial 1.1 −15.1, 20.3 Trivial
30 h of exercise duration −5.4 −35.6, 38.9 Trivial −8.1 −20.3, 6.0 Small↓*
Diet in control group −43.1 −58.9, −21.3 Small↓*** −21.9 −32.8, −9.2 Small↓**
Diet in exercise group −19.5 −44.5, 16.6 Trivial −11.1 −20.6, −0.4 Small↓*
aEvaluated at mean baseline (HOMA-IR=moderate, FAI = 8.4%), training time = 30 h, and no dietary co-intervention.
bModifying effect of baseline is evaluated for high versus low baseline.
cModifying effect of baseline is evaluated for a 3.0-fold difference in baseline.
90% CL 90% compatibility limits, ↑ increase, ↓ decrease.
Effects are shown with their observed magnitudes, determined by standardisation. Clear effects are show with the probability of either a true substantial change (*possibly, **likely, ***very
likely) and/or a true trivial change (00 likely, 000very likely). Magnitudes in bold are clear with 99% compatibility intervals.
may have a limited impact on BMI but positively improves waist
circumference or other markers of body composition, including
increased lean mass and decreased fat mass, which can occur
without changes in total body weight.
Insulin resistance is a key aetiological feature in PCOS
and underpins the metabolic dysfunction present in women
with PCOS (Dunaif et al., 1989; Diamanti-Kandarakis and
Papavassiliou, 2006). Although not currently included in the
diagnostic criteria, insulin resistance determined from insulin
clamps is prevalent in 56–95% of women with PCOS (Stepto
et al., 2013; Tosi et al., 2017; Li et al., 2019). It is therefore
important to understand the impact of exercise type and
intensity and its interaction with diet to explore effective exercise
interventions to alleviate insulin resistance in women with
PCOS before major complications occur. Resistance training
is an effective treatment for improving insulin sensitivity in
individuals with diabetes (Ishii et al., 1998; Holten et al., 2004;
Ibañez et al., 2005), however, there is limited evidence to support
the benefits of such training in PCOS (Thomson et al., 2008).
We identified moderate decreases in HOMA-IR after resistance
training interventions when compared to a control group.
Resistance training is yet to be implemented in the treatment
of PCOS, with current knowledge limited to few studies with
small numbers of participants. However, there is evidence to
support the effects of resistance training for improving insulin
sensitivity in diabetic populations and therefore this may be
applicable to women with PCOS. Our meta-analysis showed that
vigorous intensity aerobic training also resulted in moderate
decreases in HOMA-IR in women with PCOS. This is in line
with findings from a number of other clinical populations (Pattyn
et al., 2014; Weston et al., 2014; Jelleyman et al., 2015; Cassidy
et al., 2017). Results from a study conducted by Greenwood et al.
(2016) support the superior health benefits of vigorous exercise
compared to moderate exercise in women with PCOS. They
reported that 60min of vigorous intensity exercise per week was
associated with a 22% reduced odds of metabolic syndrome. In
addition, Harrison et al. (2012) reported a 16% improvement in
insulin sensitivity in women with PCOS following a 12-weeks
vigorous intensity exercise intervention, as determined by the
gold-standard euglycaemic-hyperinsulinaemic clamp method
(DeFronzo et al., 1979). The use of the clamp method in clinical
practice is impractical, however one must be cognisant that using
HOMA-IR as a surrogatemarker for IR has significant limitations
which includes a low sensitivity in identifying IR (Tosi et al.,
2017). Despite the pitfalls of using HOMA-IR to measure insulin
resistance, most clinical research in PCOS continues to use this
method due to its cost-effectiveness and ease of translation into
clinical practice.
Elevated FAI is the most consistently observed androgenic
abnormality in PCOS (Teede et al., 2011). Current research that
measures FAI prior to and following an exercise intervention
show contradictory results (Giallauria et al., 2008; Thomson et al.,
2008; Stener-Victorin et al., 2012). This may relate to the complex
relationship between FAI and insulin resistance, as the latter
has profound effects on SHBG. Results from our meta-analysis
could not provide any conclusive evidence in support of any type
of exercise training or exercise intensity influencing FAI and is
consistent with another recent meta-analysis (Kite et al., 2019).
Our results suggest that resistance trainingmay be the most likely
to induce positive changes in FAI, however, due to the limited
number of studies utilising resistance training, more research is
required to validate this outcome. One study of 16 week study
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of progressive resistance training (n = 45) reported decreases in
FAI values of 0.82% (Miranda-Furtado et al., 2016). In addition,
a study comparing a 10-weeks intervention of either resistance
training (n = 8) or high intensity interval training (n = 8) to a
control group (n= 9), reported the largest decrease in FAI in the
strength training group, with a decrease of −0.7% from baseline
values (Almenning et al., 2015). Although resistance training
shows promising results, reductions in FAI have also been
reported after aerobic exercise (Randeva et al., 2002; Giallauria
et al., 2008; Covington et al., 2015). Further research is required
to determine the effective modality, dose and intensity of exercise
for improvements in hyperandrogenism. There is also a need to
identify more valid measures of androgen levels in women with
PCOS to monitor impacts all interventions (e.g., exercise and/or
diet, pharmacotherapies).
Strengths and Limitations
An important strength of our analysis is the inclusion of a
variety of study designs with well-characterised participants.
This allowed us to go beyond existing systematic reviews and
meta-analyses to generate a large dataset that included a no-
intervention control group. We were also able to explore
the modifying effects of diet, exercise intensity, training dose,
and baseline values of the outcome measures, according to
a particular current health and fitness level, enabling more
individualised exercise prescription for women with PCOS.
However, the inclusion of studies other than RCTs may be
viewed as a limitation due to the possible increase in the risk of
bias. However, all studies were assessed for bias and deemed of
acceptable quality. It could also be argued that including a no-
exercise control group in a study design could be considered of
no additional use (Jones and Podolsky, 2015; Frieden, 2017) and
it is established that in many clinical conditions, most outcomes
impacted by exercise remain unchanged or worsen over the
course of an intervention in no-exercise controls (Jelleyman et al.,
2015). A limitation of this analysis is the large heterogeneity
among the included studies with interventions varying greatly
in frequency, intensity, and the extent of exercise supervision.
Some studies had sparse description of the exercise interventions,
further limiting our analysis. The inclusion of unsupervised
exercise interventions may have under-estimated the benefits of
exercise and future research should aim to document level of
supervision to better gauge its effect on clinical outcomes.
CONCLUSIONS
This work considerably expands on previous evidence and
advances the knowledge of benefits of exercise prescription
in women with PCOS. Our analysis demonstrates that
exercise training in women with PCOS improves cardio-
metabolic outcomes, both in the presence and independent
of anthropometric changes, supporting the role of exercise
therapy, as the first-line approach for improving health
outcomes in women with PCOS. Specifically, for greater
health improvements, exercise interventions and/or exercise
prescription should aim to achieve and sustain a minimum of
20 h of vigorous intensity exercise over 10–12 weeks, equating to
120min per week across this timeframe. Once achieving this goal,
women should sustain this level of exercise for continued health
maintenance. Resistance training also appears to have some
health benefits and could be considered for women with PCOS.
Adequate reporting of exercise intervention characteristics (i.e.,
exercise session supervision, exercise intensity, adherence, and
compliance), use of gold-standard clinical outcome measures
and consideration of long-term intervention sustainability
is required through the application of high-quality, large
clinical studies of longer duration required to provide
definitive exercise prescription recommendations in women
with PCOS.
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